Jharkhand: RIMS director gets HC notice for failing to submit Lalu's health report

The high court has scheduled the next hearing in the matter on February 19, giving "one last chance" to the RIMS director to submit Lalu Prasad's health report.

Published On 2021-02-06 04:30 GMT   |   Update On 2021-02-06 04:30 GMT

Ranchi: The Jharkhand High Court on Friday issued a show-cause to the director of Rajendra Institute of Medical Sciences for not submitting the health report of jailed Rashtriya Janata Dal (RJD) chief Lalu Prasad. The court observed that the report is vital to ascertain the reason behind shifting Prasad to Delhi's All India Institute of Medical Sciences (AIIMS) on January 23. Also Read:...

Login or Register to read the full article

Ranchi: The Jharkhand High Court on Friday issued a show-cause to the director of Rajendra Institute of Medical Sciences for not submitting the health report of jailed Rashtriya Janata Dal (RJD) chief Lalu Prasad.

The court observed that the report is vital to ascertain the reason behind shifting Prasad to Delhi's All India Institute of Medical Sciences (AIIMS) on January 23.

Also Read: Serum Institute fire incurred damages worth over Rs 1000 crore, probe to reveal cause

He was moved to the national capital for apparent pneumonia, but no specific health issue has been reported by AIIMS so far, officials have said.

The high court has scheduled the next hearing in the matter on February 19, giving "one last chance" to the RIMS director to submit Prasad's health report.

Prasad (72), convicted in fodder scam cases, has been undergoing treatment at RIMS for multiple ailments. 

Also Read:Doctors at Indraprastha Apollo Hospitals report 50 decline in paediatric cancer diagnosis

Tags:    
Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News